21961-31-9Relevant academic research and scientific papers
COMPOUNDS, COMPOSITIONS AND METHODS OF USE
-
, (2020/07/06)
Herein, compounds, compositions and methods for modulating inclusion formation and stress granules in cells related to the onset of neurodegenerative diseases, musculoskeletal diseases, cancer, ophthalmological diseases, and viral infections are described.
NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES
-
Page/Page column 245-246, (2011/11/01)
A compound of formula (I) as well as pharmaceutically acceptable salt thereof, wherein R1 to R5 have the significance given in claim 1, can be used as a medicament.
NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES
-
Page/Page column 91, (2011/10/31)
A compound of formula (I) as well as pharmaceutically acceptable salt thereof, wherein R1 to R5 have the significance given in claim 1, can be used as a medicament.
SUBSTITUTED PIPERIDINES AS CCR3 ANTAGONISTS
-
Page/Page column 60, (2010/11/03)
Object of the present invention are novel substituted compounds of the formula 1, wherein A, R1, R2, R3 and R4 are defined as in the description. Another object of the present invention is to provide antagonists of CCR3, more particularly to provide pharmaceutical compositions comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of at least one of the compounds of the present invention or a pharmaceutically acceptable salt thereof.
QUINAZOLINE DERIVATIVES AS ANTIVIRAL AGENTS
-
Page/Page column 35, (2010/11/26)
The present invention relates to the use of quinazoline derivatives of formula (I) wherein A, B, R1, R2, R3 and R4 are defined herein, and pharmaceutically acceptable salts thereof, for the treatment or preventi
